STOCK TITAN

Tenon Medical Inc - TNON STOCK NEWS

Welcome to our dedicated news page for Tenon Medical (Ticker: TNON), a resource for investors and traders seeking the latest updates and insights on Tenon Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Tenon Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Tenon Medical's position in the market.

Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ: TNON) reported a 354% year-over-year revenue increase to $944,000 in Q3 2023. Gross profit margin rose to 57%, a 31 basis points sequential increase. Surgical procedures using the Catamaran System surged by 329%. The company concluded the quarter with the surgical launch of the JIB Instrument Kit, and secured a $10 million equity line of credit facility with Lincoln Park Capital Fund. Additionally, Tenon passed FDA's Level 2 Quality System Inspection with no observations, objectionable conditions, or Form 483 issued.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.42%
Tags
-
Rhea-AI Summary
Tenon Medical, Inc. announced that the US Food and Drug Administration (FDA) has concluded a full Quality System Inspection Technique (QSIT) Level 2 Inspection at Tenon Medical. The inspection found no objectionable conditions or violations of the Food Drug and Cosmetic (FD&C) Act. Tenon Medical received a Pass, indicating their focus on quality and strict operational procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
49.41%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ:TNON) plans to release its financial results for Q3 2023 on November 14, 2023, after market close. A conference call will be held at 4:30 p.m. Eastern Time on the same day to discuss the results. Dial-in details and webcast information are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Tenon Medical, Inc. announces a 1:10 reverse stock split of its common stock to increase the per share market price and meet the listing requirements of the Nasdaq Capital Market. The split will be effective on November 2, 2023, and the new trading symbol will be 'TNON'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
511.51%
Tags
none
-
Rhea-AI Summary
Tenon Medical expands use of JIB instrument kit for Catamaran fixation device, successfully performed cases at Zion Surgery Center
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.5%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. withdraws proposed public offering of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.69%
Tags
Rhea-AI Summary
Tenon Medical announces proposed public offering of common stock. All shares being offered by Tenon. Offering subject to market conditions. Maxim Group LLC acting as sole placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Tenon Medical reports Q2 2023 revenue of $743,000, a 450% YoY increase. Gross profit turns positive at 26%. 469% increase in surgical procedures using The Catamaran System. Closed $5.6 million public offering. Cash and cash equivalents at $6.3 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.93%
Tags
-
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ:TNON) plans to release its financial results for Q2 2023 on August 8, 2023, after market close. The company will also hold a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results. Dial-in details and webcast information are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
Rhea-AI Summary
Tenon Medical, Inc. has closed its public offering of 10,000,000 units, with each unit consisting of one share of common stock and two warrants. The units were sold at a public offering price of $0.56, resulting in gross proceeds of approximately $5.6 million. The warrants began trading on the Nasdaq Capital Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.55%
Tags
Tenon Medical Inc

Nasdaq:TNON

TNON Rankings

TNON Stock Data

2.99M
3.35M
10.15%
15.07%
4%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United States
Los Gatos